Bioxcel Therapeutics Logo
Previous slide
Next slide

Innovative Medicine
Backed by the
Power of AI

BioXcel Therapeutics, Inc., a clinical-stage biopharmaceutical company developing transformative medicines in neuroscience and immuno-oncology utilizing artificial intelligence, or AI, techniques.

Innovative Medicine
Backed by the Power of AI

BioXcel Therapeutics, Inc., a clinical-stage biopharmaceutical company developing transformative medicines in neuroscience and immuno-oncology utilizing artificial intelligence, or AI, techniques.

Our AI-based approach is designed to:

Latest News

May 28, 2024
BioXcel Therapeutics to Present at Jefferies Global Healthcare ConferenceVIEW RELEASE
May 21, 2024
BioXcel Therapeutics Announces Oral and Poster Presentations at the 2024 American Society of Clinical Psychopharmacology (ASCP) Annual MeetingVIEW RELEASE
May 09, 2024
BioXcel Therapeutics Reports First Quarter 2024 Financial ResultsVIEW RELEASE

Stock Information

BioXcel Therapeutics, Inc.

Jun 21, 2024 04:00 PM

MARKET/SYMBOL

Nasdaq:

BTAI

PRICE

1.14

CHANGE

0 (0%)
Scroll to Top

The information provided on this site is intended for use by healthcare professionals practicing in the US. The dissemination of this information may be subject to different medical and regulatory requirements in other countries. This web site is intended to help healthcare professionals practicing in the US find scientifically balanced, evidence-based information about Bioxcel Therapeutics drugs, submit a question, ask for field medical follow-up, and explore links to professional and patient support resources.